Braimah, Imoro Zeba <br/><br/>
Intravitreal ziv-aflibercept for the treatment of choroidal neovascularisation associated with conditions other than age-related macular degeneration.  [electronic resource] 

 -  The British journal of ophthalmology  09 2017 
 - 1201-1205 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1468-2079 
<br/><br/><label>Standard No.: </label>10.1136/bjophthalmol-2016-309994  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--adverse effects<br/>Choroid Diseases--complications<br/>Choroidal Neovascularization--diagnosis<br/>Female<br/>Fluorescein Angiography<br/>Humans<br/>Intravitreal Injections<br/>Macular Degeneration--complications<br/>Male<br/>Middle Aged<br/>Optical Imaging<br/>Receptors, Vascular Endothelial Growth Factor--therapeutic use<br/>Recombinant Fusion Proteins--adverse effects<br/>Retinal Diseases--complications<br/>Retrospective Studies<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--physiology<br/>Young Adult